CUFinder

Tarek Mouhieddine

Tarek Mouhieddine

Harvard University

H-index: 24

North America-United States

Contact Tarek Mouhieddine

About Tarek Mouhieddine

Tarek Mouhieddine, With an exceptional h-index of 24 and a recent h-index of 23 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Genomics, Immunotherapy, Multiple myeloma, Smoldering myeloma, MGUS.

His recent articles reflect a diverse array of research interests and contributions to the field:

Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes

Comparative efficacy of carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) in newly‐diagnosed multiple myeloma: A …

Post CAR-T lymphocytosis as a surrogate of BCMA CAR-T expansion, response, and prognosis in multiple myeloma

Clinical outcomes and evolution of clonal hematopoiesis in patients with newly diagnosed multiple myeloma

Abstract IA050: Biomarker benchmarking across ancestral populations

Safety and activity of immune checkpoint inhibitors in people living with HIV and cancer: A real-world report from the cancer therapy using checkpoint inhibitors in people …

Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors

Revisiting the role of alkylating agents in multiple myeloma: Up-to-date evidence and future perspectives

Tarek Mouhieddine Information

University

Position

Dana-Farber Cancer Institute

Citations(all)

2643

Citations(since 2020)

2152

Cited By

1037

hIndex(all)

24

hIndex(since 2020)

23

i10Index(all)

37

i10Index(since 2020)

35

Email

University Profile Page

Google Scholar

Tarek Mouhieddine Skills & Research Interests

Genomics

Immunotherapy

Multiple myeloma

Smoldering myeloma

MGUS

Top articles of Tarek Mouhieddine

Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes

Journal for immunotherapy of cancer

2024

Talal El Zarif
Talal El Zarif

H-Index: 3

Lucia Kwak
Lucia Kwak

H-Index: 12

Arjun Ravishankar
Arjun Ravishankar

H-Index: 4

Alessio Cortellini
Alessio Cortellini

H-Index: 17

Shruti Gupta
Shruti Gupta

H-Index: 4

Kaushal Parikh
Kaushal Parikh

H-Index: 14

Elio Adib
Elio Adib

H-Index: 3

So Yeon Kim
So Yeon Kim

H-Index: 6

Comparative efficacy of carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) in newly‐diagnosed multiple myeloma: A …

2024/4/12

Post CAR-T lymphocytosis as a surrogate of BCMA CAR-T expansion, response, and prognosis in multiple myeloma

Cancer Research

2024/3/22

Tarek Mouhieddine
Tarek Mouhieddine

H-Index: 16

Markus Mapara
Markus Mapara

H-Index: 24

Ruben Niesvizky
Ruben Niesvizky

H-Index: 42

Clinical outcomes and evolution of clonal hematopoiesis in patients with newly diagnosed multiple myeloma

Cancer Research Communications

2023/12/18

Robert Redd
Robert Redd

H-Index: 21

Matthew Leventhal
Matthew Leventhal

H-Index: 6

Chip Stewart
Chip Stewart

H-Index: 51

Gad Getz
Gad Getz

H-Index: 174

Abstract IA050: Biomarker benchmarking across ancestral populations

Cancer Epidemiology, Biomarkers & Prevention

2023/12/1

Elio Adib
Elio Adib

H-Index: 3

Sarah Abou Alaiwi
Sarah Abou Alaiwi

H-Index: 6

Talal El Zarif
Talal El Zarif

H-Index: 3

Stefan Groha
Stefan Groha

H-Index: 5

Pier Vitale Nuzzo
Pier Vitale Nuzzo

H-Index: 11

Kodi Taraszka
Kodi Taraszka

H-Index: 3

Muhieddine Labban
Muhieddine Labban

H-Index: 1

Chris Labaki
Chris Labaki

H-Index: 2

Deborah Schrag
Deborah Schrag

H-Index: 74

Safety and activity of immune checkpoint inhibitors in people living with HIV and cancer: A real-world report from the cancer therapy using checkpoint inhibitors in people …

Journal of Clinical Oncology

2023/7/20

Talal El Zarif
Talal El Zarif

H-Index: 3

Elio Adib
Elio Adib

H-Index: 3

Jiaming Huang
Jiaming Huang

H-Index: 1

Chul Kim
Chul Kim

H-Index: 14

Elie Kozaily
Elie Kozaily

H-Index: 2

Tarek Haykal
Tarek Haykal

H-Index: 10

Alessio Cortellini
Alessio Cortellini

H-Index: 17

Vishal Shah
Vishal Shah

H-Index: 4

Parminder Singh
Parminder Singh

H-Index: 3

Danai Dima
Danai Dima

H-Index: 27

Carlo Genova
Carlo Genova

H-Index: 6

Giuseppe Lamberti
Giuseppe Lamberti

H-Index: 13

Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors

2023/6/1

Wint Yan Aung
Wint Yan Aung

H-Index: 5

Chung-Shien Lee
Chung-Shien Lee

H-Index: 3

Revisiting the role of alkylating agents in multiple myeloma: Up-to-date evidence and future perspectives

2023/5/25

Immune Dynamics Associated with Patient Outcomes Identified By Multimodal Single-Cell Analysis in Multiple Myeloma Patients Receiving Talquetamab Monotherapy

Blood

2023/11/28

Bhaskar Upadhyaya
Bhaskar Upadhyaya

H-Index: 4

Santiago Thibaud
Santiago Thibaud

H-Index: 5

Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma

Blood advances

2023/3/28

Oliver Van Oekelen
Oliver Van Oekelen

H-Index: 3

Santiago Thibaud
Santiago Thibaud

H-Index: 5

Sridevi Rajeeve
Sridevi Rajeeve

H-Index: 2

Outcomes with panobinostat in heavily pretreated multiple myeloma patients

2023/3/24

Angela Lee
Angela Lee

H-Index: 24

Multimodal Single-Cell Transcriptomic and Proteomic Correlatives of Patients Outcomes Following Anti-BCMA Cellular Therapy with Ciltacabtagene Autoleucel (Cilta-cel) in …

Blood

2023/11/28

Sherry Bhalla
Sherry Bhalla

H-Index: 11

Oliver Van Oekelen
Oliver Van Oekelen

H-Index: 3

Sridevi Rajeeve
Sridevi Rajeeve

H-Index: 2

Bhaskar Upadhyaya
Bhaskar Upadhyaya

H-Index: 4

Santiago Thibaud
Santiago Thibaud

H-Index: 5

Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy

Blood

2023/2/16

Oliver Van Oekelen
Oliver Van Oekelen

H-Index: 3

Santiago Thibaud
Santiago Thibaud

H-Index: 5

MinimuMM-seq: Genome sequencing of circulating tumor cells for minimally invasive molecular characterization of multiple myeloma pathology

Cancer discovery

2023/2/6

Ziao Lin
Ziao Lin

H-Index: 5

Chip Stewart
Chip Stewart

H-Index: 51

Gad Getz
Gad Getz

H-Index: 174

Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell support

Bone Marrow Transplantation

2023/1

Santiago Thibaud
Santiago Thibaud

H-Index: 5

Clinical Outcomes of Subsequent Therapies in Patients with Relapsed/Refractory Multiple Myeloma Following Talquetamab Treatment: Analyses from the Phase 1/2 MonumenTAL-1 Study

Blood

2023/11/28

Outcomes after CAR T Cells in Multiple Myeloma Patients with Extramedullary and Paramedullary Disease

Blood

2023/11/28

Santiago Thibaud
Santiago Thibaud

H-Index: 5

Demographic Disparities in Clinical Trial Enrollment of US Patients with Newly-Diagnosed Multiple Myeloma

Blood

2023/11/28

Neha Debnath
Neha Debnath

H-Index: 2

Inflammatory Biomarkers and Outcomes in Multiple Myeloma Patients after CAR T-Cell Therapy

Blood

2023/11/28

Santiago Thibaud
Santiago Thibaud

H-Index: 5

Timing of Vaccination Impacts Serological Response to COVID-19 Myeloma Patients after BCMA-Targeted CAR T

Blood

2023/11/28

Oliver Van Oekelen
Oliver Van Oekelen

H-Index: 3

Bhaskar Upadhyaya
Bhaskar Upadhyaya

H-Index: 4

Santiago Thibaud
Santiago Thibaud

H-Index: 5

Florian Krammer
Florian Krammer

H-Index: 68

See List of Professors in Tarek Mouhieddine University(Harvard University)

Co-Authors

academic-engine

Useful Links

List of top 50 universities
List of top 100 universities
List of top 500 universities
Find Professors Email
Find Universities Email
CUFinder Academic Engine